InvestorsHub Logo
Followers 94
Posts 11188
Boards Moderated 0
Alias Born 11/02/2003

Re: None

Friday, 05/20/2016 12:10:46 PM

Friday, May 20, 2016 12:10:46 PM

Post# of 24335
http://www.reuters.com/article/us-lungcancer-breathalyzer-idUSKCN0YA1G8

Cambridge-based Owlstone Medical connection with peters is interesting

Did anyone know Joseph Peters was Former Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance Committee
Advance Nanotech, Inc., through its equity interest in Owlstone Nanotech Inc., engages in the commercialization of chemical sensor products based on its proprietary gas sensing technology in the United States. The company markets Lonestar, a chemical sensing product. Lonestar is a functional unit for certain applications in industrial markets, as well as a test platform for partners providing an integrated and deployable chemical detection system. It also offers OVG-4, a system for generating trace concentration levels of chemicals and calibration gas standards for the purpose of testing and calibrating sensor systems in laboratory and field deployment; ADS, an ion mobility device that can identify both type and concentration of target gases; and FAIMS mass spectrometer interface, which provides the opportunity for users to integrate Owlstone’s core microchip sensor with existing mass spectrometers. The company was founded in 2004 and is headquartered in Montebello, New York. On March 15, 2011, an involuntary petition for liquidation under Chapter 7 was filed against Advance Nanotech, Inc.in the U.S. Bankruptcy Court for the District of Delaware, Delaware.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VNTH News